Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: A meta-analysis

Inflammation Research

Volumn 60, Issue 1, 2011, Pages 11-18

  Zhang, Guo Long ^a,c   Zou, Yan Feng ^b   Feng, Xiao Liang ^b   Shi, He Jian ^a,c   Du, Xu Feng ^a,c   Shao, Min Hua ^c   Gu, Yong ^c   Zhou, Qing ^a,c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Autoimmune; Genetic polymorphisms; Inflammatory diseases; Meta analysis; NFKBIA

Indexed keywords

ARTICLE; AUTOIMMUNE DIABETES MELLITUS; AUTOIMMUNE DISEASE; CROHN DISEASE; DISEASE PREDISPOSITION; ENTERITIS; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INFLAMMATORY DISEASE; MULTIPLE SCLEROSIS; NFKBIA GENE; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

AUTOIMMUNE DISEASES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION; POLYMORPHISM, GENETIC; PUBMED;

EID: 78651365954     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-010-0216-2     Document Type: Article

References (45)

1. KF Tait T Marshall J Berman J Carr-Smith B Rowe JA Todd, et al. 2004 Clustering of autoimmune disease in parents of siblings from the Type 1 diabetes Warren repository Diabet Med 21 358 362 1:STN:280:DC%2BD2c7lslaksA%3D%3D 10.1111/j.1464-5491.2004.01162.x 15049939
2. KG Becker 1999 Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways? Diabetes 48 1353 1358 1:CAS:528:DyaK1MXktFantb4%3D 10.2337/diabetes.48.7.1353 10389838
3. KG Becker 2004 The common variants/multiple disease hypothesis of common complex genetic disorders Med Hypotheses 62 309 317 1:CAS:528: DC%2BD2cXhtVOlurs%3D 10.1016/S0306-9877(03)00332-3 14962646
4. PJ Barnes M Karin 1997 Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1066 1071 1:CAS:528:DyaK2sXis1SrsLw%3D 10.1056/NEJM199704103361506 9091804
5. PA Baeuerle 1998 Pro-inflammatory signaling: last pieces in the NFkappaB puzzle? Curr Biol 8 R19 R22 1:STN:280:DyaK1c%2FovFWltw%3D%3D 10.1016/S0960-9822(98)70010-7 9427616
6. PP Tak GS Firestein 2001 NF-kappaB: a key role in inflammatory diseases J Clin Invest 107 7 11 1:CAS:528:DC%2BD3MXitVOhtg%3D%3D 10.1172/JCI11830 11134171
7. S Castro-Alcaraz V Miskolci B Kalasapudi D Davidson I Vancurova 2002 NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis J Immunol 169 3947 3953 1:CAS:528:DC%2BD38XnsFeltbY%3D 12244195
8. S Schreiber S Nikolaus J Hampe 1998 Activation of nuclear factor kappa B inflammatory bowel disease Gut 42 477 484 1:STN:280:DyaK1c3nvFakuw%3D%3D 10.1136/gut.42.4.477 9616307
9. G Rogler K Brand D Vogl S Page R Hofmeister T Andus, et al. 1998 Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa Gastroenterology 115 357 369 1:CAS:528:DyaK1cXltl2nsrY%3D 10.1016/S0016-5085(98)70202-1 9679041
10. MF Neurath I Fuss G Schürmann S Pettersson K Arnold H Müller-Lobeck, et al. 1998 Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease Ann N Y Acad Sci 859 149 159 1:CAS:528:DyaK1MXitVCmsw%3D%3D 10.1111/j.1749-6632.1998.tb11119.x 9928378
11. MF Neurath S Pettersson 1997 Predominant role of NF-kappa B p65 in the pathogenesis of chronic intestinal inflammation Immunobiology 198 91 98 1:CAS:528:DyaK1cXktFWrsQ%3D%3D 9442381
12. RH Duerr MM Barmada L Zhang R Pfützer DE Weeks 2000 High-density genome scan in Crohn disease shows confirmed linkage to chromosome 14q11-12 Am J Hum Genet 66 1857 1862 1:CAS:528:DC%2BD3cXntV2jur8%3D 10.1086/302947 10747815
13. XF Sun H Zhang 2007 NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases Histol Histopathol 22 1387 1398 1:CAS:528:DC%2BD2sXhtlaksL7I 17701919
14. T Szamosi PL Lakatos Hungarian IBD Study Group A Szilvasi L Lakatos A Kovacs, et al. 2009 The 3′UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients Dig Dis Sci 54 351 359 1:CAS:528: DC%2BD1MXhtlOqtLg%3D 10.1007/s10620-008-0351-6 18716880
15. R Dieguez-Gonzalez S Akar M Calaza E Perez-Pampin J Costas M Torres, et al. 2009 Genetic variation in the nuclear factor kappaB pathway in relation to susceptibility to rheumatoid arthritis Ann Rheum Dis 68 579 583 1:CAS:528:DC%2BD1MXkt1emtLo%3D 10.1136/ard.2007.087304 18434448
16. J Hong E Leung AG Fraser TR Merriman P Vishnu GW Krissansen 2007 Polymorphisms in NFKBIA and ICAM-1 genes in New Zealand Caucasian Crohn's disease patients J Gastroenterol Hepatol 22 1666 1670 1:CAS:528: DC%2BD2sXht1yltbnK 10.1111/j.1440-1746.2007.05020.x 17593226
17. K Katarina P Daniela N Peter R Marianna C Pavlina P Stepanka, et al. 2007 HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients Exp Clin Endocrinol Diabetes 115 124 129 1:CAS:528: DC%2BD2sXjvVynurY%3D 10.1055/s-2007-949589 17318773
18. E Leshinsky-Silver A Karban S Cohen M Fridlander O Davidowich G Kimmel, et al. 2007 Lack of association of the 3′-UTR polymorphism in the NFKBIA gene with Crohn's disease in an Israeli cohort Int J Colorectal Dis 22 1021 1025 1:STN:280:DC%2BD2srnsVamug%3D%3D 10.1007/s00384-007-0287-x 17333217
19. M Romzova D Hohenadel K Kolostova D Pinterova M Fojtikova S Ruzickova, et al. 2006 NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications Hum Immunol 67 706 713 1:CAS:528:DC%2BD28XpvV2gsLg%3D 10.1016/j.humimm.2006.05.006 17002901
20. C Butt S Sun L Peddle C Greenwood S Hamilton D Gladman, et al. 2005 Association of nuclear factor-kappaB in psoriatic arthritis J Rheumatol 32 1742 1744 1:CAS:528:DC%2BD2MXhtFSktb7P 16142871
21. W Klein A Tromm C Folwaczny M Hagedorn N Duerig JT Epplen, et al. 2004 A polymorphism of the NFKBIA gene is associated with Crohn's disease patients lacking a predisposing allele of the CARD15 gene Int J Colorectal Dis 19 153 156 10.1007/s00384-003-0531-y 13680285
22. A Abdallah H Sato JC Grutters S Veeraraghavan PA Lympany HJ Ruven, et al. 2003 Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis Genes Immun 4 450 454 1:CAS:528:DC%2BD3sXms12qu7Y%3D 10.1038/sj.gene.6364001 12944982
23. B Miterski S Böhringer W Klein E Sindern M Haupts S Schimrigk, et al. 2002 Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations Genes Immun 3 211 219 1:CAS:528:DC%2BD38XksFCisrg%3D 10.1038/sj.gene.6363846 12058256
24. YH Hung TT Ou CH Lin RN Li YC Lin WC Tsai, et al. 2009 IkBalpha promoter polymorphisms in patients with ankylosing spondylitis Rheumatol Int 30 93 97 1:CAS:528:DC%2BD1MXhsVCisbzN 10.1007/s00296-009-0923-6
25. CH Lin SC Wang TT Ou RN Li WC Tsai HW Liu, et al. 2008 I kappa B alpha promoter polymorphisms in patients with systemic lupus erythematosus J Clin Immunol 28 207 213 1:CAS:528:DC%2BD1cXltFOqtL8%3D 10.1007/s10875-007-9156-1 18071880
26. TT Ou CH Lin YC Lin RN Li WC Tsai HW Liu, et al. 2008 IkappaBalpha promoter polymorphisms in patients with primary Sjögren's syndrome J Clin Immunol 28 440 444 1:CAS:528:DC%2BD1cXhtVyjt7bP 10.1007/s10875-008-9212-5 18600435
27. CH Lin TT Ou CC Wu WC Tsai HW Liu JH Yen 2007 IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis Int J Immunogenet 34 51 54 1:CAS:528:DC%2BD2sXitlymu7Y%3D 10.1111/j.1744-313X.2007.00660.x 17284228
28. M Egger SG Davey M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test Br Med J 315 629 634 1:STN:280:DyaK2svls1KjtA%3D%3D
29. WG Cochran 1954 The combination of estimates from different experiments Biometrics 10 101 129 10.2307/3001666
30. JP Higgins SG Thompson 2002 Quantifying heterogeneity in a meta-analysis Stat Med 21 1539 1558 10.1002/sim.1186 12111919
31. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
32. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 1:STN:280:DyaL2s7gsVamtA%3D%3D 10.1016/0197-2456(86)90046-2 3802833
33. Q Li IM Verma 2002 NF-kappaB regulation in the immune system Nat Rev Immunol 2 725 734 1:CAS:528:DC%2BD38XnsVGqsbg%3D 10.1038/nri910 12360211
34. S Uwe 2008 Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks Biochem Pharmacol 75 1567 1579 1:CAS:528:DC%2BD1cXlslChurg%3D 10.1016/j.bcp.2007.10.027 18070616
35. A Kuryłowicz J Nauman 2008 The role of nuclear factor-kappaB in the development of autoimmune diseases: a link between genes and environment Acta Biochim Pol 55 629 647 19081854
36. S Beinke SC Ley 2004 Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology Biochem J 382 393 409 1:CAS:528:DC%2BD2cXmvVOnsb0%3D 10.1042/BJ20040544 15214841
37. JR Berenson HM Ma R Vescio 2001 The role of nuclear factor-kappaB in the biology and treatment of multiple myeloma Semin Oncol 28 626 633 1:CAS:528:DC%2BD38XjvVSmuw%3D%3D 10.1016/S0093-7754(01)90036-3 11740821
38. VG Bhoj ZJ Chen 2009 Ubiquitylation in innate and adaptive immunity Nature 458 430 437 1:CAS:528:DC%2BD1MXjs1KlsLc%3D 10.1038/nature07959 19325622
39. JW Christman RT Sadikot TS Blackwell 2000 The role of nuclear factor-kappa B in pulmonary diseases Chest 117 1482 1487 1:CAS:528: DC%2BD3cXjvFSgsrk%3D 10.1378/chest.117.5.1482 10807839
40. JJ Haddad SC Land 2002 Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IkappaB-alpha/NF-kappaB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium Am J Respir Cell Mol Biol 26 114 126 1:CAS:528: DC%2BD38XmslKqsw%3D%3D 11751211
41. CG Yoo S Lee CT Lee YW Kim SK Han YS Shim 2000 Anti-inflammatory effect of heat shock protein induction is related to stabilization of I kappa B alpha through preventing I kappa B kinase activation in respiratory epithelial cells J Immunol 164 5416 5423 1:CAS:528:DC%2BD3cXjt1Gku74%3D 10799907
42. JJ Haddad SC Land WO Tarnow-Mordi M Zembala D Kowalczyk R Lauterbach 2002 Immunopharmacological potential of selective phosphodiesterase inhibition. II. Evidence for the involvement of an inhibitory-kappaB/nuclear factor-kappaB-sensitive pathway in alveolar epithelial cells J Pharmacol Exp Ther 300 567 576 1:CAS:528:DC%2BD38Xos1yrsA%3D%3D 10.1124/jpet.300.2.567 11805218
43. ST Whiteside A Israël 1997 I kappa B proteins: structure, function and regulation Semin Cancer Biol 8 75 82 1:CAS:528:DyaK2sXmtlGqsb0%3D 10.1006/scbi.1997.0058 9299585
44. I Okafuji R Nishikomori N Kanazawa N Kambe A Fujisawa S Yamazaki, et al. 2009 Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis Arthritis Rheum 60 242 250 1:CAS:528: DC%2BD1MXhvFCjsr0%3D 10.1002/art.24134 19116920
45. Y He H Zhang J Yin J Xie X Tan S Liu, et al. 2009 IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C Carcinogenesis 30 1916 1922 1:CAS:528:DC%2BD1MXhsV2jtb3M 10.1093/carcin/bgp226 19797428